Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis.

Soon Sun Kim Jung Woo Eun Hyo-Jung ChoDo Seon SongChang Wook KimYoung Seok KimSung Won LeeYoon-Keun KimJinho YangJinhee ChoiHyung Joon Yim Jae-Youn Cheong

Published in: Alimentary pharmacology & therapeutics (2020)

Dysbiosis was confirmed in severe AH but was alleviated by rifaximin treatment. Taxa associated with severe AH can be candidate biomarkers or therapeutic targets.

Keyphrases

early onset
drug induced
liver injury
human health
replacement therapy